Products

Ligence Heart
Ligence
Cardiology AI
Ligence Heart is an AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers.

See all 1 product →

About Ligence

Ligence is a health technology company that specializes in AI-powered automation for echocardiography analysis. Their flagship product, Ligence Heart, is designed to streamline the workflow for cardiologists by automating measurements and reporting from cardiac ultrasound images. This technology aims to reduce the time spent on manual tasks, allowing physicians to focus more on patient care and critical decision-making. The software integrates with existing hospital systems like PACS and provides transparent, guideline-based measurements aligned with ASE and ESC standards, offering clinicians full visibility into a patient’s cardiac health.

The Ligence Heart platform reads DICOM data, recognizes image views and heart cycles, performs measurements, and generates reports. It is intended for use in adult patients in sinus rhythm and can assist in detecting pathologies such as systolic dysfunction, pulmonary hypertension, and heart failure. The company emphasizes that its AI-driven echocardiography does not replace clinicians but supports them by providing consistent, expert-level analysis, even in time-pressured environments. Ligence’s solutions are designed to enhance diagnostic accuracy, improve efficiency, and ultimately lead to better patient outcomes in cardiovascular care.

Focus Areas

Medical Imaging Medical AI Healthcare Analytics Computer Vision Echocardiography Cardiology AI Cardiac Reporting Software Global Longitudinal Strain TTE Analysis PACS Integration EHR Integration

Business Intelligence

TechnologyCloud-native, AI-powered software platform, deep learning, neural networks, integrates with PACS and EHR systems

What Physicians Need to Know

Medical Imaging & Echocardiography
Ligence specializes in AI-powered echocardiography analysis and reporting software, primarily with its product 'Ligence Heart'. This platform automates the evaluation of heart ultrasound images, providing detailed analysis of cardiac structures and functions. It aims to improve accuracy and efficiency in cardiac diagnostics by automating measurements and reporting, thereby reducing manual workload for cardiologists. The software can detect pathologies such as systolic dysfunction, pulmonary hypertension, and heart failure. It also supports automated analysis of 2D transthoracic echocardiography (TTE) images, including view recognition, cardiac cycle phase detection, and measurement calculation.
Medical AI & Computer Vision
Ligence leverages deep learning technology and advanced machine learning for its AI solutions. The AI-driven software automatically identifies standard echocardiographic views, detects the cardiac cycle and anatomical borders, and performs precise contour tracking. It has demonstrated accuracy comparable to, and in some cases surpassing, human cardiologists in measurements like left ventricular function and aortic valve hemodynamics. The AI also assists in detecting early-stage heart failure by identifying subtle changes in heart structure.
Healthcare Analytics & Cardiac Reporting Software
Ligence Heart automates the generation of comprehensive echocardiography reports in local languages, based on the AI-driven analysis. This streamlines workflows, reduces reporting time, and enhances diagnostic precision. The software provides structured reports with key cardiac structural and functional parameters. It also aims to reduce operator variability, ensuring consistent measurements crucial for follow-up care.
Global Longitudinal Strain (GLS) & TTE Analysis
Ligence Heart offers fully automated Left Ventricular Global Longitudinal Strain (LV GLS) analysis, which is critical for early detection of myocardial dysfunction. This automation addresses the traditionally complex and time-intensive manual contouring required for strain analysis. The software also provides segmental strain measurements alongside standard quantitative automated measures. It is specifically designed for analyzing echocardiographic images of adult patients in sinus rhythm.
Key Differentiators
Ligence's key differentiators include its AI surpassing human performance in certain echocardiographic analyses, such as left ventricular function measurements. The company was founded by physicians and engineers, ensuring a blend of clinical expertise and technological depth, with AI built and refined in daily collaboration with cardiologists. Their software aims to provide consistent, expert-level analysis even in time-pressured clinical environments. Ligence Heart has received FDA 510(k) clearance, enabling its use in the U.S. market.
Technology Stack
Ligence Heart is an AI-driven fully automated echocardiography analysis post-processing suite. It utilizes deep learning technology to imitate the typical steps of a cardiologist, including image view recognition and cardiac cycle phase detection. The software reads DICOM format data. It is designed to integrate seamlessly with existing hospital systems.
Physician Tip

Ligence Heart aims to significantly reduce the time cardiologists spend on manual measurements and reporting, allowing them to focus more on patient assessment and critical decision-making. The automated analysis provides highly accurate and consistent measurements, reducing inter-observer variability and improving diagnostic reliability, especially for follow-up care. The software's intuitive interface and automated features, including Global Longitudinal Strain analysis, make advanced diagnostics more accessible and efficient, even for those less accustomed to such tools. Physicians can review and adjust AI-generated measurements and reports, maintaining clinical control while benefiting from increased efficiency. The integration with existing PACS and EHR systems further streamlines workflows.

Ligence Heart is designed for seamless integration with existing PACS and EHR systems, helping cardiologists streamline workflows. It reads DICOM format data. The Blackford Platform, for example, is purpose-built for seamless integration with current systems and simplifies the management of multiple AI applications. Ligence is also developing integration with the Sectra Echo Viewer.

Products by Ligence

1 product in the directory

Ligence Heart
Ligence
Cardiology AI
Ligence Heart is an AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography, enhancing diagnostic efficiency and accuracy for cardiologists and sonographers.

Videos

News, demos, and interviews about Ligence.

Loading videos...

Videos load interactively. If none appear, search YouTube for Ligence →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Ligence Heart is an AI-powered software designed for automated analysis and reporting of 2D transthoracic echocardiography (TTE) studies. It streamlines the diagnostic process by automatically segmenting cardiac structures, performing measurements, and detecting pathologies like heart failure, pulmonary hypertension, and systolic dysfunction. This automation reduces manual workload, enhances diagnostic accuracy and consistency, and allows clinicians to focus more on patient care.
Ligence Heart is a web-based, fully integrated echocardiography analysis suite that seamlessly integrates with existing hospital systems, including PACS and EHR. It captures images from ultrasound machines, automatically annotates them, and generates reports, significantly cutting down on the time cardiologists and sonographers spend on manual measurements and reporting. This integration aims to reduce scan times and improve overall workflow efficiency in echo labs.
Ligence Heart assists in the diagnosis and monitoring of various cardiovascular conditions, including systolic dysfunction, pulmonary hypertension, and heart failure. It provides detailed analysis of cardiac parameters, aiding in the assessment of conditions like coronary artery disease, valvular disorders, and cardiomyopathies. The software's consistent measurements are particularly valuable for tracking disease progression and treatment response over time.
Ligence Heart is CE-Marked, classifying it as a Class IIa medical device under the European Commission's MDR 2017/745 framework. Additionally, it has received FDA 510(k) clearance in the United States, enabling its use by healthcare providers in the U.S. for automated and manual analysis of adult 2D TTE images and reporting.
While specific pricing details require direct vendor contact, Ligence Heart is generally offered with a one-time license fee based on the number of installations. Ligence provides comprehensive customer support, including dedicated customer service contact channels ([email protected]) and readily available user manuals and release notes for their software.
Ligence has established strategic partnerships to broaden its market reach and enhance its offerings. Notable collaborations include Blackford, an imaging AI platform provider, to make Ligence Heart available on their platform, and HealthCare Konnect for distribution in Switzerland and North Africa. They also partner with AI4CMR to deliver a combined multimodality solution for cardiac imaging.
Founded in 2019 in Lithuania, Ligence is a health-tech startup focused on AI-driven cardiac ultrasound analysis. The company has demonstrated financial stability by securing significant funding, including u20ac6 million in total funding, with a u20ac3 million seed round led by Simpact Ventures and a convertible loan from the European Innovation Council Fund. They are actively expanding globally, indicating a strong growth trajectory.

Related Companies

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Samsung Medison Co. is a global medical equipment company specializing in diagnostic imaging devices, particularly ultrasound systems. Established in 1985, the company has become the largest manufacturer of ultrasound systems in Korea. Samsung Medison integrates advanced technologies, including information technology, video signal processing, semiconductors, and communication, into its medical equipment. This integration enables the development […]

Medtronic is a global leader in healthcare technology, developing and manufacturing a vast array of medical devices and therapies. The company’s mission is to alleviate pain, restore health, and extend life for people with chronic conditions worldwide. Medtronic operates in over 150 countries, offering solutions across four main business units: Cardiovascular, Neuroscience, Medical Surgical, and […]

Philips Medical Systems Nederland B.V. is a key entity within Royal Philips, a leading global health technology company. The company focuses on improving people’s health and well-being through meaningful innovation, leveraging advanced technology and deep clinical and consumer insights to deliver integrated solutions. [6, 29] For physicians, this translates into a commitment to developing AI-enabled […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.